Celularity Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$107M
↓-19.1% -$25Mvs FY2024
Total Liabilities
$145M
↑+17.4% +$22Mvs FY2024
Cash
$6M
↑+736.7% +$5Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $107M | $133M |
| Current Assets | $12M | $21M |
| Cash | $6M | $738K |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $571K | $5M |
| Other Current | $6M | $14M |
| Non-Current Assets | $95M | $112M |
| PPE | $56M | $62M |
| Goodwill | $7M | $7M |
| Intangibles | $8M | $9M |
| Investments | $0 | $0 |
| Other Non-Current | $24M | $34M |
| Total Liab+Eq | $107M | $133M |
| Current Liab. | $81M | $54M |
| Accounts Payable | $26M | $23M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $2M | $4M |
| Other CL | $52M | $27M |
| Non-Current Liab. | $65M | $70M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $65M | $70M |
| Equity | $-38M | $9M |
| Retained Earnings | $991M | $900M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · CELU · Comparing FY2025 vs FY2024